Seeing Is Believing
Currently out of the existing stock ratings of James Gordon, 23 are a BUY (35.94%), 39 are a HOLD (60.94%), 2 are a SELL (3.13%).
Analyst James Gordon, currently employed at JPMORGAN, carries an average stock price target met ratio of 59.52% that have a potential upside of 30.82% achieved within 209 days. Previously, James Gordon worked at BAML.
James Gordon’s has documented 127 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GRFS, Grifols SA ADR at 17-Jun-2025.
Analyst best performing recommendations are on GRFS (GRIFOLS SA ADR).
The best stock recommendation documented was for GRFS (GRIFOLS SA ADR) at 1/3/2023. The price target of $9.09 was fulfilled within 1 day with a profit of $0.35 (4%) receiving and performance score of 40.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87.4
1 months 9 days ago
(20-May-2025)
3/3 (100%)
$19.88 (29.44%)
386
Buy
$99
$11.19 (12.74%)
$106
1 months 15 days ago
(14-May-2025)
8/11 (72.73%)
$11.76 (13.48%)
108
Buy
$110
$22.19 (25.27%)
$110
1 months 15 days ago
(14-May-2025)
15/26 (57.69%)
$22.76 (26.09%)
393
Buy
$120
$32.19 (36.66%)
$105
3 months 1 days ago
(28-Mar-2025)
8/10 (80%)
$24.23 (25.30%)
338
Buy
$108
$20.19 (22.99%)
$110
4 months 2 days ago
(27-Feb-2025)
7/10 (70%)
$16.03 (17.43%)
282
Which stock is James Gordon is most bullish on?
What Year was the first public recommendation made by James Gordon?